Diagnostic and Prognostic Models

106 Items

All Items

WFDC3 identified as a prognostic and immune biomarker in pancreatic cancer

Bohan Liu, Xuqing Shi, Tianqi Liu, Huanwen Wu, Zhiyong Liang

2447–2465
VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

Lidija Todorović, Boban Stanojević

26-36
- PDF
- XML
UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer: A proteomic approach

Kongfan Zhu, Hua Hu, Yuanfa Tao, Zhijian Yang, Hanjun Li

2466–2480
Tumor hypoxia: Classification, detection, and its critical role in cancer progression

Yan Zhao, Bing Zhong, Jing-Yi Cao, Qian Wang, Jie Liang, Ke Lu, Sheng-Ming Lu

1672–1690
- PDF
Tumor budding in preoperative breast biopsies predicts sentinel lymph node metastasis

Songul Peltek Ozer, Bahri Ozer, Gulali Aktas

662–667
- PDF
The value of elastography strain rate ratio in benign and malignant BI-RADS-US 3-4 breast masses

Xinping Li, Weixu Sun, Hongbiao Zhang

625–632
- PDF
The role of the NY-ESO-1 in the prognosis of gastric cancer

Zvonimir Misir, Goran Glavčić, Suzana Janković, Ivan Kruljac, Jakša Čugura Filipović, Kristina Čimić, Monika Ulamec

813-820
The role of COPD in survival of NSCLC patients receiving immune checkpoint inhibitors: A meta-analysis

Yan Zhu, Chongyang Wang

2428–2438
- PDF
The relationship between tumor budding and survival of patients with breast cancer: A meta-analysis

Hongjie Xu, Dajun Wei

1546–1558
- PDF
The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

Zhen Pan, Ye Wang, Shoufeng Li, Huajun Cai, Guoxian Guan

612–624
- PDF
The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade

Yuchen Zhang, Chen Yang, Yanchao Xu, Xiang Jiang, Jiajun Shi, Binghua Li, Decai Yu

1314–1321
The impact of MITF expression on tumor-infiltrating lymphocytes in melanoma: Insights into immune microenvironment dynamics

Damir Vučinić, Matea Lekić, Gordana Žauhar, Gordana Zamolo

2050–2057
- PDF
The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances

Maja Pezer Naletilić, Krešimir Tomić, Kristina Katić, Zoran Gatalica, Gordan Srkalović, Eduard Vrdoljak, Semir Vranić

2594–2606
- PDF
The diagnostic accuracy of exosomes for glioma: A meta-analysis

XiangMin Zhang, YanDi Tan, XiaoYa He, Jie Huang, XiaoYing Ni, Qian Hu, JinHua Cai

541–552
- PDF
The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk

Tatiana Zavarykina, Maria Kapralova, Polina Lomskova, Aleksandra Asaturova, Grigory Khabas, Lyailya Kayumova, Dmitry Khodyrev, Irina Pronina, Maya Sannikova, Svetlana Khokhlova

1197–1204
- PDF
Systemic analysis of the expression and prognostic significance of USP31 in endometrial cancer

Yuzhen Huang, Peng Jiang, Yuting Chen, Jinyu Wang, Rui Yuan

426–436
SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

Hang Jiang, Zhiqian Xue, Liping Zhao, Boyuan Wang, Chenfei Wang, Haihan Song, Jianjun Sun

1231–1243
- PDF
SOX-9 as a prognostic marker in gastric adenocarcinoma

Efe Yetişgin, Aysun Gökçe, Kutsal Doğan

1982–1991
- PDF
Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration

Xuefei Wang, Fangqi Deng, Jiexi Liu, Jiayu Wang, Qing Chen, Jiabin Lu

912-922
- PDF
Serum ferritin as a prognostic biomarker in CAR-T therapy for multiple myeloma: A meta-analysis

Jing Cheng, Yuan Song

2416–2427
- PDF

1-20 of 106 Next

Diagnostic and Prognostic Models

All Items

WFDC3 identified as a prognostic and immune biomarker in pancreatic cancer

VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer: A proteomic approach

Tumor hypoxia: Classification, detection, and its critical role in cancer progression

Tumor budding in preoperative breast biopsies predicts sentinel lymph node metastasis

The value of elastography strain rate ratio in benign and malignant BI-RADS-US 3-4 breast masses

The role of the NY-ESO-1 in the prognosis of gastric cancer

The role of COPD in survival of NSCLC patients receiving immune checkpoint inhibitors: A meta-analysis

The relationship between tumor budding and survival of patients with breast cancer: A meta-analysis

The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade

The impact of MITF expression on tumor-infiltrating lymphocytes in melanoma: Insights into immune microenvironment dynamics

The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances

The diagnostic accuracy of exosomes for glioma: A meta-analysis

The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk

Systemic analysis of the expression and prognostic significance of USP31 in endometrial cancer

SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

SOX-9 as a prognostic marker in gastric adenocarcinoma

Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration

Serum ferritin as a prognostic biomarker in CAR-T therapy for multiple myeloma: A meta-analysis

impact_factor_6

Sidebar_menu